carbostyril has been researched along with Carcinoma, Non-Small Cell Lung in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Dang, TPT; Nguyen, PAT; Nguyen, TAT; Nguyen, TH; Nguyen, THT; Phung, NKP; Truong, TBN | 1 |
| Gao, HY; Guo, H; Hu, Q; Liang, LJ; Rao, Y; Wang, GZ; Xie, DW; Yang, YQ; Yu, H; Zhao, Q; Zhou, GB | 1 |
| Augeri, DJ; Bommareddy, PK; Carayannopolous, MO; Chesson, CB; Dobias, NS; Goedken, M; Jabbour, SK; Jhawar, SR; Kerrigan, JE; Langenfeld, E; Langenfeld, J; Lee, MJ; Li, S; Malhotra, J; Marshall, S; Minerowicz, C; NeMoyer, R; Newman, JH; Sadimin, ET; Tarabichi, S; Zloza, A | 1 |
| Du, SS; Fan, L; Feng, JB; Liu, JX; Qi, XS; Su, X; Tian, M; Wang, CF; Wang, YY | 1 |
| Das, M; Frymoyer, A; Neal, JW; Padda, SK; Riess, JW; Wakelee, HA; Zhou, L | 1 |
| Ahn, JS; Ahn, MJ; Ahn, S; Cho, BC; Choi, YL; Kim, HR; Kim, JH; Lee, JY; Lee, SH; Lim, SH; Park, K; Sun, JM | 1 |
| Chamni, S; Chanvorachote, P; Charupant, K; Mori, N; Saito, N; Sirimangkalakitti, N; Suwanborirux, K | 1 |
| Bankovic, J; Dragoj, M; Milosevic, Z; Pesic, M; Stankovic, T; Tanic, N | 1 |
| Le Moulec, S; Loriot, Y; Soria, JC | 1 |
| Li, M; Liu, A; Liu, B; Luo, X; Yu, H; Zheng, H | 1 |
| Busceti, MT; Caraglia, M; Falcone, D; Fratto, D; Gallelli, L; Maselli, R; Pelaia, G; Renda, T; Savino, R; Terracciano, R; Vatrella, A | 1 |
| Adjei, AA; Bruzek, L; Erlichman, C; Geyer, S; Hanson, LJ; Hillman, S; Kaufmann, SH; Marks, RS; Mauer, A; Vokes, EE; Wright, JJ | 1 |
| Khuri, FR | 1 |
| Heymach, JV; Johnson, BE | 1 |
2 review(s) available for carbostyril and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Primary and secondary prevention of non-small-cell lung cancer: the SPORE Trials of Lung Cancer Prevention.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Chemoprevention; Clinical Trials as Topic; Disease Progression; Epidermal Growth Factor; Gefitinib; Humans; Lung Neoplasms; Precancerous Conditions; Protein-Tyrosine Kinases; Quinazolines; Quinolones | 2003 |
Farnesyl transferase inhibitors for patients with lung cancer.
Topics: Alkyl and Aryl Transferases; Apoptosis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Clinical Trials as Topic; Farnesyltranstransferase; Humans; Imidazoles; Lung Neoplasms; Quinolones; Signal Transduction; Treatment Outcome | 2004 |
3 trial(s) available for carbostyril and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Dovitinib and erlotinib in patients with metastatic non-small cell lung cancer: A drug-drug interaction.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carcinoma, Non-Small-Cell Lung; Drug Interactions; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Neoplasm Metastasis; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); Quinolones; Receptors, Vascular Endothelial Growth Factor; Retreatment; Treatment Outcome | 2015 |
Efficacy and safety of dovitinib in pretreated patients with advanced squamous non-small cell lung cancer with FGFR1 amplification: A single-arm, phase 2 study.
Topics: Aged; Aged, 80 and over; Benzimidazoles; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Gene Amplification; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prognosis; Quinolones; Receptor, Fibroblast Growth Factor, Type 1; Survival Rate | 2016 |
Phase II study of the farnesyl transferase inhibitor R115777 in patients with advanced non-small-cell lung cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Alkyl and Aryl Transferases; Anemia; Carcinoma, Non-Small-Cell Lung; Disease Progression; Farnesyltranstransferase; Female; Humans; Leukocytes, Mononuclear; Lung Neoplasms; Male; Middle Aged; Mouth Mucosa; Neutropenia; Quinolones; Survival | 2003 |
9 other study(ies) available for carbostyril and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Three quinolinone alkaloid - phenylpropanoid adducts from
Topics: Alkaloids; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Quinolones; Rutaceae | 2022 |
Upregulation of wild-type p53 by small molecule-induced elevation of NQO1 in non-small cell lung cancer cells.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Lung Neoplasms; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Quinolones; Reactive Oxygen Species; RNA, Small Interfering; Tumor Suppressor Protein p53; Up-Regulation | 2022 |
Novel bone morphogenetic protein receptor inhibitor JL5 suppresses tumor cell survival signaling and induces regression of human lung cancer.
Topics: A549 Cells; Adoptive Transfer; Animals; Antineoplastic Agents; Bone Morphogenetic Protein Receptors; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Humans; Inhibitor of Differentiation Protein 1; Lung Neoplasms; MAP Kinase Kinase Kinases; Mice; Mice, Inbred NOD; Mice, SCID; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Quinolones; Signal Transduction; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2018 |
Radiosensitizing effect of schinifoline from Zanthoxylum schinifolium Sieb et Zucc on human non-small cell lung cancer A549 cells: a preliminary in vitro investigation.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Gamma Rays; Humans; Lung Neoplasms; Quinolones; Radiation-Sensitizing Agents; Radiation, Ionizing; Sesquiterpenes; Tumor Stem Cell Assay; Zanthoxylum | 2014 |
Chemistry of Renieramycins. 15. Synthesis of 22-O-Ester Derivatives of Jorunnamycin A and Their Cytotoxicity against Non-Small-Cell Lung Cancer Cells.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Screening Assays, Antitumor; Humans; Isoquinolines; Marine Biology; Molecular Structure; Porifera; Quinolones; Structure-Activity Relationship; Tetrahydroisoquinolines; Thailand | 2016 |
Targeting CXCR4 and FAK reverses doxorubicin resistance and suppresses invasion in non-small cell lung carcinoma.
Topics: Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; Benzylamines; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Doxorubicin; Drug Resistance, Neoplasm; Focal Adhesion Kinase 1; Gene Expression Profiling; Humans; Lung Neoplasms; Multidrug Resistance-Associated Proteins; Neoplasm Invasiveness; Quinolones; Real-Time Polymerase Chain Reaction; Receptors, CXCR4; Sulfones; Transcriptome | 2017 |
[Targeting KRAS pathway in NSCLC therapy].
Topics: Animals; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Non-Small-Cell Lung; Farnesyltranstransferase; Genes, ras; Humans; Lung Neoplasms; Mice; Mitogen-Activated Protein Kinase Kinases; Mutation; Neoplasm Proteins; Niacinamide; Phenylurea Compounds; Piperidines; Pyridines; Quinolones; raf Kinases; ras Proteins; Sorafenib | 2009 |
Ras homologue enriched in brain is a critical target of farnesyltransferase inhibitors in non-small cell lung cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Inhibitors; Farnesyltranstransferase; Humans; Lung Neoplasms; Mechanistic Target of Rapamycin Complex 1; Monomeric GTP-Binding Proteins; Multiprotein Complexes; Mutation; Neuropeptides; Phosphorylation; Piperidines; Prenylation; Proteins; Pyridines; Quinolones; Ras Homolog Enriched in Brain Protein; Ribosomal Protein S6; RNA Interference; RNA, Messenger; Signal Transduction; TOR Serine-Threonine Kinases; Transcription Factors; Transfection | 2010 |
Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non-small lung cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Caspase 3; Cell Line, Tumor; Cell Survival; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Farnesyltranstransferase; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lung; Lung Neoplasms; MAP Kinase Signaling System; Phosphorylation; Quinolones; Simvastatin | 2012 |